Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > American markets

<< Previous

Bullboard Posts

Next >>

Comment by jwalliscaon Nov 26, 2020 12:04pm

72 Views

Post# 31979112

RE:American markets

wk:

Historically, when the US markets take a break, Canadian markets tend to just meander around on lighter than usual volume.

Regarding SVA specifically, the US component of the total volume has always been small so "no real effect" is expected. Today, SVA is likely to trade with low volume and no real price change... give, or take that proverbial Half Cent Tango!

jwall

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December